Shanghai Fosun Pharmaceutical Group Co Ltd

CN

SHFOS

Health Care

11.82 ₽

Current price

Sell
11.82 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    1032 / 1328

  • Position in country

    6129 / 7387

  • Return on Assets, %

    2.6

    -2.7

  • Net income margin, %

    4.2

    2.8

  • EBITDA margin, %

    5.9

    10.8

  • Debt to Equity, %

    76.5

    19.2

  • Intangible assets and goodwill, %

    23

    3.6

  • Revenue CAGR 3Y, %

    10.9

    8.5

  • Revenue Y, % chg

    -10.9

    0.5

  • P/E

    12.1

    22.7

  • P/BV

    0.6

    1.5

  • P/S

    0.7

    2.3

  • EV/S

    2

    2.4

  • EV/EBITDA

    20.8

    7.4

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    68.2

    51.3

  • Forward P/E

    7.4

    15.6

  • Dividend Yield, %

    3.8

    1.7

  • Forward Dividend Yield, %

    0.4

    0.2

  • Expected dividend per share

    0

    0

  • Payout Ratio, %

    46.7

    30.3

Get an analytical review of this company

Competitors

Ranks

  • China Resources Sanjiu Medical & Pharmaceutical Co Ltd

    00%

  • Shijiazhuang Yiling Pharmaceutical Co Ltd

    00%

  • CSPC Pharmaceutical Group Ltd

    00%

  • Zhangzhou Pientzehuang Pharmaceutical Co Ltd

    00%

  • Beijing Tongrentang Co Ltd

    00%

  • Yunnan Baiyao Group Co Ltd

    00%

  • Hansoh Pharmaceutical Group Company Ltd

    00%

  • Zhejiang Nhu Co Ltd

    00%

  • Jiangsu Hengrui Pharmaceuticals Co Ltd

    00%

  • Shanghai Fosun Pharmaceutical Group Co Ltd

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    China

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    7440.6

  • Ticker

    2196.HK

  • ISIN

    CNE100001M79

  • IPO date

    1998-08-07

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-03-27

  • Date fact. publication of reports

    2023-12-31

Company Description

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products are mainly applied in the treatment of metabolism and digestive tract system, cardiovascular system, central nervous system, blood system, anti-tumor and anti-infection diseases. The Company is also engaged in medical equipment and medical diagnosis business, as well as the provision of medical services. It distributes its products primarily in domestic and overseas markets.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: